About Fluid Biomed
Fluid Biomed is a company based in Calgary (Canada) founded in 2012 by John H Wong and Alim P Mitha. It operates as a Direct-to-Consumer (D2C). Fluid Biomed has raised $32.55 million across 3 funding rounds from investors including University of Calgary, Amplitude Ventures and IAG Capital Partners. The company has 49 employees as of May 27, 2025. Fluid Biomed offers products and services including Hybrid Polymer-Metal Stent. Fluid Biomed operates in a competitive market with competitors including Rapid Medical, Cerus Endovascular, Oxford Endovascular, Anaconda Biomed and CoAxia, among others.
- Headquarter Calgary, Canada
- Employees 49 as on 27 May, 2025
- Founders John H Wong, Alim P Mitha
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$32.55 M (USD)
in 3 rounds
-
Latest Funding Round
$27 M (USD), Series A
Dec 16, 2024
-
Investors
University of Calgary
& 11 more
-
Employee Count
49
as on May 27, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fluid Biomed
Fluid Biomed offers a comprehensive portfolio of products and services, including Hybrid Polymer-Metal Stent. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A stent designed to treat brain aneurysms effectively.
Unlock access to complete
Funding Insights of Fluid Biomed
Fluid Biomed has successfully raised a total of $32.55M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $27 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $27.0M
-
First Round
First Round
(12 Feb 2020)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series A - Fluid Biomed | Valuation | Amplitude | |
| Aug, 2021 | Amount | Seed - Fluid Biomed | Valuation | Metis Innovative , ShangBay Capital | |
| Feb, 2020 | Amount | Seed - Fluid Biomed | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Fluid Biomed
Fluid Biomed has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Calgary, Amplitude Ventures and IAG Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in precision medicine companies.
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided by IAG Capital Partners.
|
Founded Year | Domain | Location | |
|
Early-stage life science companies are funded and supported.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Fluid Biomed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Fluid Biomed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Fluid Biomed Comparisons
Competitors of Fluid Biomed
Fluid Biomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, Cerus Endovascular, Oxford Endovascular, Anaconda Biomed and CoAxia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| domain | founded_year | HQ Location |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| domain | founded_year | HQ Location |
Metallic mesh devices for brain aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| domain | founded_year | HQ Location |
Catheter-based treatment for cerebral ischemia
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Fluid Biomed
Frequently Asked Questions about Fluid Biomed
When was Fluid Biomed founded?
Fluid Biomed was founded in 2012 and raised its 1st funding round 8 years after it was founded.
Where is Fluid Biomed located?
Fluid Biomed is headquartered in Calgary, Canada. It is registered at Calgary, Alberta, Canada.
Who is the current CEO of Fluid Biomed?
John H Wong is the current CEO of Fluid Biomed. They have also founded this company.
Is Fluid Biomed a funded company?
Fluid Biomed is a funded company, having raised a total of $32.55M across 3 funding rounds to date. The company's 1st funding round was a Seed of $846.72K, raised on Feb 12, 2020.
How many employees does Fluid Biomed have?
As of May 27, 2025, the latest employee count at Fluid Biomed is 49.
What does Fluid Biomed do?
Fluid Biomed is engaged in the development of advanced medical devices, specifically the next generation of polymer-based brain stents to treat aneurysms. The company operates in the healthcare sector, targeting neurovascular solutions. Their hybrid polymer-metal flow-diverting stent is designed to promote better healing of blood vessels and minimize interference with imaging tests. Solutions are engineered for flexibility, self-expansion, and patient safety, while ensuring ease of use for physicians. The innovation aims to improve patient outcomes by reducing the need for invasive follow-up tests and long-term medication.
Who are the top competitors of Fluid Biomed?
Fluid Biomed's top competitors include Rapid Medical, Anaconda Biomed and MicroVention.
What products or services does Fluid Biomed offer?
Fluid Biomed offers Hybrid Polymer-Metal Stent.
Who are Fluid Biomed's investors?
Fluid Biomed has 12 investors. Key investors include University of Calgary, Amplitude Ventures, IAG Capital Partners, LifeArc Ventures, and ShangBay Capital.